Avoid common mistakes on your manuscript.
The Editor in Chief has retracted this article because it has been previously published by the same author group [1]. This article is therefore redundant. All authors agree to this retraction. The online version of this article contains the full text of the retracted article as Supplementary Information.
Change history
18 July 2022
This article was retracted on 18 July 2022.
Reference
Wang P, Chang Z, Meng J, Cui X, Chai J, Dang T. CCN1 suppresses cell proliferation of esophageal squamous cell carcinoma through amyloid precursor protein without DR6 participation. Cell Signal. 2022;96: https://doi.org/10.1016/j.cellsig.2022.110374.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The Editor in Chief has retracted this article because it has been previously published by the same author group [1]. This article is therefore redundant. All authors agree to this retraction. The online version of this article contains the full text of the retracted article as Supplementary Information. Reference [1] Wang P, Chang Z, Meng J, Cui X, Chai J, Dang T. CCN1 suppresses cell proliferation of esophageal squamous cell carcinoma through amyloid precursor protein without DR6 participation. Cell Signal. 2022;96:110374. https://doi.org/10.1016/j.cellsig.2022.110374
Supplementary Information
Below is the link to the electronic supplementary material.
About this article
Cite this article
Wang, P., Chang, Z., Meng, J. et al. RETRACTED ARTICLE: Overexpression of CCN1 in esophageal squamous cell carcinoma attenuates cell proliferation through amyloid precursor protein without DR6 involvement. Human Cell 35, 1630 (2022). https://doi.org/10.1007/s13577-022-00726-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13577-022-00726-0